|
Volumn 28, Issue 3, 2008, Pages 367-368
|
Comments on "efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (The BOLDER II study)" by Dr Thase and colleagues
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
QUETIAPINE;
DIBENZOTHIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
BIPOLAR DEPRESSION;
BIPOLAR I DISORDER;
BIPOLAR II DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DOUBLE BLIND PROCEDURE;
EFFECT SIZE;
HUMAN;
LETTER;
MONOTHERAPY;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
BIPOLAR DISORDER;
DOSE RESPONSE;
EPIDEMIOLOGY;
NOTE;
PSYCHOLOGICAL RATING SCALE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
STATISTICAL ANALYSIS;
STATISTICS;
ANTIPSYCHOTIC AGENTS;
BIAS (EPIDEMIOLOGY);
BIPOLAR DISORDER;
DIBENZOTHIAZEPINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
HUMANS;
PSYCHIATRIC STATUS RATING SCALES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
DATA INTERPRETATION, STATISTICAL;
|
EID: 51449092444
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e318162a2df Document Type: Letter |
Times cited : (1)
|
References (2)
|